Athira Pharma, Inc. announced the appointment of Michael A. Panzara, to its Board of Directors. Dr. Panzara currently serves as Chief Medical Officer, Head of Therapeutics Discovery and Development at Wave Life Sciences and brings over 20 years of biopharmaceutical industry experience developing therapies for neurological disorders, including in leadership roles at Sanofi Genzyme and Biogen.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.56 USD | -3.03% | +0.79% | +5.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.35% | 101M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- ATHA Stock
- News Athira Pharma, Inc.
- Athira Pharma, Inc. Announces Appointment of Michael A. Panzara to its Board of Directors